Sasha Jovanovic
4 min read
-
Amdocs reported Q4 and full-year fiscal 2026 results broadly in line with guidance, with revenue of $1.19b up 3.8% year on year and earnings of $1.98 per share matching analyst expectations, while issuing fiscal 2027 guidance that points to revenue and profit declines tied to a dispute and potential contract loss with T-Mobile.
-
Alongside the weaker outlook, management highlighted a reshaping of Amdocs’ business mix through an eight-year AT&T aOS deal, multiple new telecom modernisation agreements, and the $340 million EIS acquisition, which extends its software footprint into insurance.
-
We will now see how Amdocs’ cautious 2027 guidance around T-Mobile affects the existing investment narrative built on recurring contracts.
Scan beyond Amdocs and see how other AI and telecom software plays are setting up right now with the handpicked 53 AI infrastructure stocks.
Amdocs Investment Narrative Recap
To stay comfortable as a shareholder in Amdocs, you need to believe the telecom and now insurance software platforms can keep winning long contracts around cloud, AI and aOS, even if overall telecom spending feels slow. The latest quarter basically kept that story intact on operations, but the cautious 2027 outlook makes the near term lumpier.
The key near term swing factor is the T-Mobile dispute and possible contract loss, which management already reflected in weaker 2027 guidance. That issue looks material for both revenue and profit over the next year. The biggest risk is that further guidance resets or slower aOS uptake deepen concerns about growth and earnings quality.
The eight year AT&T aOS agreement is the most relevant announcement because it sits directly opposite the T-Mobile uncertainty. Where one big customer is in dispute, another is locking in a long contract that leans heavily on Amdocs’ AI and agentic operating system ambitions.
For you, that AT&T deal matters less as a headline and more as a test of execution. If Amdocs delivers well, it can reinforce the thesis that aOS, managed services and large scale modernization programs remain a real growth driver. Any delays, scope cuts or margin pressure on this contract would quickly feed into the same concerns already showing up around guidance risk.
Amdocs’ current earnings are US$455.7 million, and analysts see that lifting to US$945.9 million by 2029, which is an earnings increase of about US$490 million. Their models assume revenue grows at 3.6% a year, reaching US$5.2 billion of sales and US$945.9 million of profit by 2029.
